– USA, OH – PatientPoint today announced the addition of Dr. Jeff Vacirca (MD, FACP) to its Board as an Independent Director.
“We are thrilled to have the opportunity to leverage the care delivery expertise of Dr. Vacirca to help us build an integrated, digital health ecosystem that will empower better health.” said Founder and CEO Mike Collette.
About Dr. Jeffrey Vacirca
Dr. Vacirca is a renowned cancer physician and visionary leader with extensive experience and commitment to community oncology. He currently serves as CEO and Chairman of the Board of New York Cancer & Blood Specialists and has led the practice through an unparalleled period of transformation and growth. Dr. Vacirca is co-founder and board member of OneOncology; medical director for the International Oncology Network, part of Cencora; and is the immediate past president of the Community Oncology Alliance. He has also served on the board of several pharmaceutical companies and has been an early investor in multiple digital health and healthcare companies, including OncoEMR, where he previously served as a medical board advisor.
Dr. Vacirca is also one of the founding members of the PatientPoint Oncology Advisory Board and has played an instrumental role in PatientPoint’s recent oncology new product initiatives and strategic partnerships.
About PatientPoint
PatientPoint is the patient engagement platform for every point of care. Our innovative, tech-enabled solutions create more effective doctor-patient interactions and deliver high value for patients, providers, and healthcare sponsors. Across the nation’s largest network of connected digital devices in over 40,000 physician offices, PatientPoint’s solutions impact roughly 750 million patient visits each year, further advancing our mission of making every doctor-patient engagement better.
SOURCE: https://patientpoint.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
